InvestorsHub Logo
Followers 13
Posts 2213
Boards Moderated 0
Alias Born 08/11/2017

Re: None

Monday, 12/09/2019 8:50:48 AM

Monday, December 09, 2019 8:50:48 AM

Post# of 1717
Efficacy, Durability of Response and Safety of Onvansertib Demonstrated in Completed Phase 1b Trial in AML Patients Presented in Oral Session at ASH

https://www.otcmarkets.com/stock/TROV/news/story?e&id=1493128
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRDF News